Short and unexpectedly potent 3-pyrrolidinone type inhibitors of HIV-1 replication

European Journal of Medicinal Chemistry

Volumn 33, Issue 6, 1998, Pages 445-450

  Bouygues, Martin ^a,b   Medou, Martial ^a,b   Chermann, Jean Claude ^b   Camplo, Michel ^a,b   Kraus, Jean Louis ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

3 Pyrrolidinone; HIV inhibitor; HIV protease; Proline isostere

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROLINE DERIVATIVE; PROTEINASE; PROTEINASE INHIBITOR; PSEUDOPEPTIDE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LIPOPHILICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0032100139     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80045-7     Document Type: Article

References (18)

1. [1] Pearl L.H., Taylor W.R., Nature 328 (1987) 482-482.
2. [2] Henderson L., Benveniste R., Sowder R., Copeland T., Schultz A., Oroszlan S., J. Virol. 62 (1988) 2587-2595.
3. [3] Schechter I., Berger A., Biochem. Biophys. Res. Commun. 27 (1967) 157-162.
4. [4] Schneider J., Kent S.B.H., Cell 54 (1988) 363-368.
5. [5] Darke P.L., Nutt R.F., Brady S.F., Garsky V.M., Ciccarone T.M., Leu C.T., Lumma P.K., Freidinger R.M., Veber D.F., Sigal I.S., Biochem. Biophys. Res. Commun. 156 (1988) 297-303.
6. [6] Billich S., Knoop M.T., Hansen J., Strop P., Sedlacek J., Mertz R., Moelling K., J. Biol Chem. 263 (1988) 7905-7908.
7. [7] Kräusslich H.G., Ingraham R.H., Skoog M.T., Wimmer E., Pallai P.V., Carter C.A., Proc. Natl. Acad. Sci. USA 86 (1989) 807-811.
8. [8] Huff J.R., J. Med. Chem. 34 (1991) 2305-2314.
9. [9] Dreyer G.B., Metcalf B.W., Tomaszek T.A., Carr T.J., Chandler A.C., Hyland L., Fakhoury S.A., Magaard V.W., Moore M.L., Strickler J.E., Debouck C., Meek T.D., Proc. Natl. Acad. Sci. USA 86 (1989) 9752-9756.
10. [10] Greenlee W.J., Med. Res. Rev. 10 (1990) 173-236.
11. [11] Thaisrivongs S., Ann. Rep. Med. Chem. 29 (1994) 133-134.
12. [12] Siedlecka R., Skarzewski J., Mlochowski J., Tetrahedron Lett. 31 (1990) 2177-2180.
13. [13] Bajwa J.S., Tetrahedron Lett. 33 (1992) 2299-2302.
14. [14] Welch J.T., Lin J., Tetrahedron 52 (1996) 291-304.
15. [15] Rey F., Barré-Sinoussi F., Schimidtmayerova H., Chermann J.C., J. Virol. Meth. 16 (1987) 239-249.
16. [16] Rey F., Donker G., Hirsch I., Chermann J.C.,Virology 181 (1991) 165-171.
17. [17] Schirlin D., Baltzer S., Van DorsserlaerV., Weber F., Weill C., Altenburger J.M., Neises B., Flynn G., Rémy J.M., Tarnus C., Bioorg. Med. Chem. Lett. 3 (1993) 253-258.
18. [18] Debouck C., AIDS Res. Human Retrov. 8 (1992) 153-164.